Multimedia > Cartoons >


Pfizer forecasts $54 billion dollars in 2022 with the surging sales of its Covid-19 shots & treatment

2 Sep 2022


Pfizer forecasts $54 billion dollars in 2022 with the surging sales of its Covid-19 shots & treatment alone.

Even if still in the clinical trials phase, and results have not turned out great, the Covid-19 pill Paxlovid will reach about $22 billion, not counting future contracts yet to be closed. Pfizer’s shares have skyrocketed to a record high on Tuesday, the day of this announcement.

Contradictory enough, Pfizer and other Big Pharma companies have declared they will “leave the not-for-profit prices and start exercising for-profit prices in 2022”.

What the heck kind of prices were they “exercising” before?

The world needs 22 billion doses to bring this nightmare to an end. The for-profit rationale will keep us dependent on Big Pharma’s monopoly and stuck in a variant-after-variant cycle, while they sit on an ever-growing chest of cash.

#Fem4PeoplesVaccine #TRIPSWaiver #Pfizer #BigPharma